{"id":"NCT03607539","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","briefTitle":"Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC","officialTitle":"A Randomized, Double-blinded, Phase III Study of Pemetrexed Plus Platinum Chemotherapy With or Without Sintilimab (IBI308) in First Line Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Subjects (Orient-11)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-08-23","primaryCompletion":"2023-02-13","completion":"2023-02-13","firstPosted":"2018-07-31","resultsPosted":"2021-02-16","lastUpdate":"2023-02-27"},"enrollment":397,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lung Neoplasms"],"interventions":[{"type":"DRUG","name":"Sintilimab","otherNames":["IBI308"]},{"type":"DRUG","name":"Pemetrexed","otherNames":[]},{"type":"DRUG","name":"Platinum","otherNames":[]},{"type":"DRUG","name":"Placebos","otherNames":[]}],"arms":[{"label":"Sintilimab in combination with pemetrexed and platinum","type":"EXPERIMENTAL"},{"label":"Sitilimab Placebo Comparator","type":"PLACEBO_COMPARATOR"}],"summary":"Efficacy and Safety Evaluation of IBI308 in Patients with advanced or metastatic Non-squamous NSCLC","primaryOutcome":{"measure":"Progression-Free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as Assessed by Independent Radiographic Review Committee (IRRC)","timeFrame":"Trough Database Cutoff Date of 15-Nov-2019 (Up to approximately 16 months)","effectByArm":[{"arm":"Sintilimab Combination","deltaMin":8.9,"sd":null},{"arm":"Placebo Combination","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["China"]},"refs":{"pmids":["39884222","39084935","35917647","32781263"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":75,"n":266},"commonTop":["Anaemia","Neutrophil count decreased","White blood cell count decreased","Nausea","Aspartate aminotransferase increased"]}}